Breast Care

Papers
(The TQCC of Breast Care is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Kombinationstherapie bei HER2+ mBC59
How Can Oncoplastic Breast Surgery Contribute to the Management of Locally Advanced Breast Cancer in Sub-Saharan Africa?39
PharmaNews27
St. Gallen/Vienna 2025 Summary of Key messages on therapy in Early Breast Cancer from the 2025 St. Gallen International Breast Cancer Conference (SGBCC)26
Front & Back Matter20
Acknowledgement to Reviewers19
Predictors for Upgrade to Breast Cancer in Patients with B3 Lesions Diagnosed by Core Biopsy: A Retrospective Cohort Study18
Comparing the Efficacy of Intralesional Injection versus Systemic Steroids in Treating Idiopathic Granulomatous Mastitis: Insights from a Single-Center Experience16
Nationwide Survey of German Outpatient Gynecologic Oncology Practices during the Coronavirus Disease 2019 Pandemic: Reactions to the First Wave and Future Perspectives13
Effects and Risks of Hormonal Therapy before and after BC Therapy13
HER2+ Early Breast Cancer: From Escalation via Targeted and Post-Neoadjuvant Treatment to De-Escalation12
Second-Degree Type 2 Atrioventricular Block Requiring Permanent Cardiac Pacing in Patients on CDK4/6 Inhibitors: Report of Two Cases11
Front & Back Matter11
Long-Term Survival Outcomes of Patients with Small (≤1 cm) Node-Negative HER2-Positive Breast Cancer Not Treated with Adjuvant Anti-HER2-Targeted Therapy: A 10-Year Follow-Up Study10
Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2− Breast Cancer Patients10
Impact of the National Action Plan for Antimicrobial Resistance on Antibiotic Use for Mastitis Using a Japanese Nationwide Database8
Interview ABC7: Bridging the Gap8
Refining Therapy in Patients with HER2-Positive Breast Cancer with Central Nervous System Metastasis8
PharmaNews8
Quality of Life in Patients Pre- and Post-Breast Reduction Surgery in a South African Population: A Single-Centred Patient-Based Study7
Sacituzumab govitecan: Trop-2 als Target7
Ten-Year Survival of Breast Cancer in Iran: A National Study (Retrospective Cohort Study)7
Quality of Life after Alloplastic versus Autologous Breast Reconstruction: The Influence of Patient Characteristics on Outcomes7
Using Virtual Therapy for Lymphedema and Disability Post-Mastectomy: Meta-Analysis with Systematic Review6
The risk of cardiovascular disease following aromatase inhibitor therapy for breast cancer in postmenopausal women: a systematic review and meta-analysis6
Front & Back Matter6
Tamoxifen Treatment for Pubertal Gynecomastia: When to Start and How Long to Continue6
Evolution of HER2 Targeting in Metastatic Breast Cancer6
Large-Scale Population Screening for BRCA1 and BRCA2 Ashkenazi Founder Mutations: Perspectives of Professionals Providing Oncogenetic Consultations5
Primary Prevention and Early Detection of Hereditary Breast Cancer5
Long-Term Follow-Up of High-Risk Breast Lesions at Vacuum-Assisted Biopsy without Subsequent Surgical Resection5
Society Bulletins4
Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes4
Effectiveness of Peer Support on Quality of Life and Anxiety in Breast Cancer Patients: A Systematic Review and Meta-Analysis4
Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine Response4
Clinicopathological Factors Affecting Positive Margins after Breast-Conserving Surgery: A Comparative Study of Low- and High- Volume Hospitals.4
Is 9-G DBT-Guided Vacuum-Assisted Breast Biopsy Sufficient to Completely Remove T1 Breast Cancers (below 20 mm)? Analysis of 146 Patients with Histology as Reference Standard4
Management of Idiopathic Granulomatous Mastitis: A Single Institution Experience4
Analysis of lifestyle and genetic risk factors in urban women in China who had malignant or suspected malignant breast nodules identified via breast cancer screening4
Comparison of local recurrence outcomes between breast conservation therapy and mastectomy for the treatment of breast cancer among young women: A systematic review and meta-analysis3
Treatment Outcomes according to the EndoPredict Score in ER-Positive, HER2-Negative Early Breast Cancer3
Lack of Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Early Breast Cancer3
Prophylaxis of Neutropenia with Lipegfilgrastim in Breast Cancer Patients with Dose-Dense Chemotherapy: Results of a Noninterventional Study on Therapeutic Routine in Germany (NADENS)3
Association of Aromatase Inhibitor-Induced Musculoskeletal Symptoms with Central Sensitization-Related Symptoms: A Cross-Sectional Study3
Impact of the Latest Clinical Data among Patients with Breast Cancer in Low- and Middle-Income Countries3
37. Annual Meeting of the Austrian Society of Senology. Vienna, Austria, Sept. 8–9 2023. Abstracts3
Acknowledgement to Reviewers3
Non-Surgical Site Pain in Women following Breast Cancer Surgery: A Systematic Review and Meta-Analysis3
Biologically Based Complementary and Alternative Medicine Use in Breast Cancer Patients and Possible Drug-Drug Interactions3
Banana Supplementation for Breast Cancer Surgery Patients: A Two-Center Experience3
Revisiting the Need for Breast Imaging in Young Women with Clinically Significant Breast Pain and a Normal Physical Breast Examination3
Comparison of Intermittent Pneumatic Compression Pump as Adjunct to Decongestive Lymphatic Therapy against Decongestive Therapy Alone for Upper Limb Lymphedema after Breast Cancer Surgery: A Systemati3
Expert Discussion: SABCS 20213
Keeping a Breast with Social Media: “Le Marteau Sans Maître?”3
Quality Analysis of YouTube Videos Presenting Shoulder Exercises after Breast Cancer Surgery3
<i>TP53</i> Gene Polymorphism at Codon 72 as a Response Predictor for Neoadjuvant Chemotherapy3
Front & Back Matter3
Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib3
Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20242
Expert Discussion: Highlights from ABC6: Bridging the Gap and Insights in This First Virtual ABC Conference and from 10 Years ABC Consensus2
Impact of Levonorgestrel-Releasing Intrauterine Devices on MR-Imaging of the Breast2
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 20252
Review Article a Multidisciplinary Evaluation for Advanced Supportive Care of Breast Cancer Patients2
The Challenge of Calculating EUSOMA Quality Indicators with Administrative Data: A Pilot Study in Belgium2
Evaluation of Interreader Agreement between Optimized Short and Full Breast MRI Protocols for Screening Breast Cancer in Moderate- and High-Risk Women2
Pushing the Limits of Breast-Conserving Surgery with Extreme Oncoplasty2
Translating Evidence into Practice: A Review of Clinical Practice and Outcomes following the Adoption of an Early Post-Mastectomy Discharge Protocol in a Nigerian Hospital2
Natural Language Processing to Extract Meaningful Information from a Corpus of Written Knowledge in Breast Cancer: Transforming Books into Data2
PharmaNews2
The Evolution of Educational Events during the COVID-19 Pandemic: The Experience of G.Re.T.A. Foundation2
Oncoplastic Breast Conserving Surgery: Is There a Need for Standardization? Results of a Nationwide Survey2
Cost-Effectiveness Analysis of Abemaciclib plus Fulvestrant versus Placebo plus Fulvestrant in Patients with Hormone Receptor-Positive, ERBB2-Negative Breast Cancer2
Insights from ASCO 20232
Targeted Axillary Dissection Using Surgical Marker Navigation after Neoadjuvant Systemic Treatment in Breast Cancer Patients: A Single-Center Experience2
Menopausal Hormone Therapy and the Breast: A Review of Clinical Studies2
PharmaNews2
Validation of the 21-Gene Recurrence Score Assay in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer and 0 to 3 Positive Lymph Nodes: Risk Pattern and Outcomes on a Community Level2
Are Diagnostic Delays Associated with Distress in Breast Cancer Patients?2
0.047057867050171